OPTILATER: optimal long-term survival after cancer - a cross-sectional study protocol for a quantitative survey on the care situation of long-term cancer survivors in Germany

OPTILATER:癌症患者长期生存率优化——一项关于德国长期癌症幸存者护理状况的定量调查横断面研究方案

阅读:2

Abstract

BACKGROUND: Cancer survivors in Germany face considerable challenges related to the late and long-term effects of treatment and a lack of post-treatment support. Despite an increasing number of cancer survivors, existing healthcare systems are insufficiently adapted to meet their ongoing needs, particularly for long-term survivors who may experience physical, emotional, and socio-economic hardships. This study aims to address the knowledge gaps in the care situation of long-term cancer survivors, focusing on their experiences and the barriers they face in accessing care. METHODS: This study protocol outlines the methodology for a quantitative survey involving up to 3,300 long-term cancer survivors across various cancer types in Germany. The survey assesses their experiences with cancer care, focusing on diet, exercise, mental health, sleep, cognition, overall health-related quality of life, and somatic late effects. Special attention is given to survivors from diverse socio-demographic backgrounds, including those with a migration history, in order to explore the unique challenges they face. DISCUSSION: The results of the study will contribute to the development of needs-based care recommendations for cancer survivors, particularly those in potentially vulnerable groups. The findings will inform the design of more inclusive care strategies and interventions, leading to better long-term health outcomes for cancer survivors in Germany. TRIAL REGISTRATION: German Clinical Trials Register: DRKS00032146, registered on 03/12/2024.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。